The cost-effectiveness of alendronate in the management of osteoporosis

John A. Kanis, Judith Adams, Fred Borgström, Cyrus Cooper, Bengt Jönsson, Danielle Preedy, Peter Selby, Juliet Compston

October 3 2007

John A. Kanis
WHO Collaborating Centre for Metabolic Bone Diseases,
University of Sheffield Medical School,
Beech Hill Road, Sheffield S10 2RX, UK

Judith Adams
Clinical Radiology, University of Manchester,
Manchester, UK

Fred Borgström
i3/Innovus, Stockholm,
Sweden and Medical Management Centre,
Karolinska Institute, Stockholm, Sweden

Cyrus Cooper
MRC Epidemiology Resource Centre,
University of Southampton, Southampton, UK

Bengt Jönsson
Stockholm School of Economics, Stockholm, Sweden

Danielle Preedy
National Osteoporosis Society, Bath, UK

Peter Selby
Department of Medicine, Manchester Royal Infirmary,
Manchester, UK

Juliet Compston
University of Cambridge School of Clinical Medicine,
Cambridge, UK


Aging clinical and experimental research offers a multidisciplinary forum on the progressing field of gerontology and geriatrics. The areas covered by the journal include: biogerontology, neurosciences, epidemiology, clinical gerontology and geriatric assessment, social, economical and behavioral gerontology. “Aging clinical and experimental research” appears bimonthly and publishes review articles, original papers and case reports.

Discover the official journal of ESCEO on and read the journal contents on
You can get the table of contents of every new issue published in Aging Clinical and Experimental Research. Sign up for the ToC Alert for this journal with your e-mail address. It’s easy and it’s free.